Abstract: The present disclosure relates to a NFC communication system, to a method of establishing communication between a wireless communication device and a passive NFC device and to a passive NFC device. The passive NFC device includes an NFC controller, an NFC transceiver coupled with the NFC controller, and at least one persistent flag coupled with the NFC controller, the persistent flag being switchable between an activated state and a deactivated state. The NFC controller is configured to perform a logical operation being divisible into a sequence of at least a first subtask and a second subtask and the NFC controller is configured to ascertain the status of the persistent flag. The NFC controller is further configured to selectively perform at least one of the first subtask and the second subtask on the basis of the status of the persistent flag.

Abstract: The present disclosure relates to a NFC communication system, to a method of establishing communication between a wireless communication device and a passive NFC device and to a passive NFC device. The passive NFC device includes an NFC controller, an NFC transceiver coupled with the NFC controller, and at least one persistent flag coupled with the NFC controller, the persistent flag being switchable between an activated state and a deactivated state. The NFC controller is configured to perform a logical operation being divisible into a sequence of at least a first subtask and a second subtask and the NFC controller is configured to ascertain the status of the persistent flag. The NFC controller is further configured to selectively perform at least one of the first subtask and the second subtask on the basis of the status of the persistent flag.

Abstract: The invention relates to crystalline salts of a compound having the structure of formula (I), methods for their preparation, and related pharmaceutical compositions comprising the crystalline salt. The invention further relates to methods of treating or preventing cancer or an immunological or neurological disease comprising administering a crystalline salt of the invention.

Abstract: A method for providing identification and access with respect to a passive radio-frequency tag in a tag population, the passive tag being configured for receiving ACK commands including an identification parameter, the method including receiving an initiating command for identifying and accessing a tag, the initiating command including a slot number having a first value if a value in a slot counter of the tag is equal to the first value, then transitioning to an Open or a Secured state, otherwise transitioning to an Arbitrate state in a case where the tag has transitioned to the Arbitrate state, receiving a command for repeating a tag access request, referred to as repetition command, the command including a slot number having a second value, different from the first value, the second value being equal to the value in the slot counter of the tag, transitioning to the Open or Secured state, receiving an ACK command, ignoring the ACK command.

Abstract: The invention relates to crystalline salts of a compound having the structure of formula (I), methods for their preparation, and related pharmaceutical compositions comprising the crystalline salt. The invention further relates to methods of treating or preventing cancer or an immunological or neurological disease comprising administering a crystalline salt of the invention.

Abstract: The invention relates to crystalline salts of a heterocyclic compound, methods of their preparation, and related pharmaceutical preparations thereof. The invention further relates to methods of treatment using the crystalline salts of the invention.

Abstract: A method for providing identification and access with respect to a passive radio-frequency tag in a tag population, the passive tag receiving ACK commands includes an identification parameter in the form of a 16-bit number. The method includes a step of receiving a command for initiating an inventory round or a command for initiating a tag access, generating a 16-bit value referred to as first or second binding handle, backscattering the first or second binding handle, receiving an ACK command, and analyzing the identification parameter of the ACK command, and in a case where the identification parameter includes the reader identifier then ignoring the ACK command.

Abstract: Process for preparing metyrapone type compounds are generally described herein. In particular, one step process for preparing metyrapone type compounds are described herein. Such processes generally include an alpha-carbon arylation coupling reaction between 3-isobutyrylpyridine and 3-halopyridine compounds in the presence of a palladium catalyst and a phosphine ligand to form the metyrapone-type compounds.

Abstract: The method relates to a method for providing identification and access with respect to a passive radio-frequency tag in a tag population, the passive tag being configured for receiving ACK commands comprising an identification parameter in the form of a 16-bit number, said method comprising the following steps: receiving a command for initiating an inventory round or a command for initiating a tag access, said command comprising, as a parameter, a number comprising an identifier of a reader generating a 16-bit value referred to as first or second binding handle, said first or second binding handle comprising N juxtaposed bits forming the reader identifier backscattering said first or second binding handle receiving an ACK command analyzing the identification parameter of said ACK command, and in a case where said identification parameter comprises the reader identifier then ignoring said ACK command.

Abstract: A method for providing identification and access with respect to a passive radio-frequency tag in a tag population, the passive tag being configured for receiving ACK commands including an identification parameter, the method including receiving an initiating command for identifying and accessing a tag, the initiating command including a slot number having a first value if a value in a slot counter of the tag is equal to the first value, then transitioning to an Open or a Secured state, otherwise transitioning to an Arbitrate state in a case where the tag has transitioned to the Arbitrate state, receiving a command for repeating a tag access request, referred to as repetition command, the command including a slot number having a second value, different from the first value, the second value being equal to the value in the slot counter of the tag, transitioning to the Open or Secured state, receiving an ACK command, ignoring the ACK command.

Abstract: Process for preparing metyrapone type compounds are generally described herein. In particular, one step process for preparing metyrapone type compounds are described herein. Such processes generally include an alpha-carbon arylation coupling reaction between 3-isobutyrylpyridine and 3-halopyridine compounds in the presence of a palladium catalyst and a phosphine ligand to form the metyrapone-type compounds.

Abstract: The present invention concerns a mutual authentication method in a communication system. According to the method, a first communication device (1), such as an RFID reader, authenticates a second communication device (3), such as an RFID tag, by using an asymmetric authentication protocol based on a generated a session key. The tag authenticates the reader by using a symmetric communication protocol based on a generated other session key. At least a portion of the session key is used to generate the other session key.

Abstract: The invention relates to crystalline salts of a heterocyclic compound, methods of their preparation, and related pharmaceutical preparations thereof. The invention further relates to methods of treatment using the crystalline salts of the invention.

Abstract: This invention provides a method for the synthesis of a 2-amino-4,6-dimethoxybenzamide and other benzamides of Compound I: wherein R1, R2, R3, and R4 each independently represent a hydrogen, a C1-C6 alkyl, or a C1-C6 alkoxy; and wherein R6 and R7 each independently represent a hydrogen, a C1-C6 alkyl, a protecting group, or a directing group.

Abstract: This invention provides a method for the synthesis of a 2-amino-4,6-dimethoxybenzamide and other benzamides of Compound I: wherein R1, R2, R3, and R4 each independently represent a hydrogen, a C1-C6 alkyl, or a C1-C6 alkoxy; and wherein R6 and R7 each independently represent a hydrogen, a C1-C6 alkyl, a protecting group, or a directing group.

Abstract: The present invention concerns a mutual authentication method in a communication system. According to the method, a first communication device (1), such as an RFID reader, authenticates a second communication device (3), such as an RFID tag, by using an asymmetric authentication protocol based on a generated a session key. The tag authenticates the reader by using a symmetric communication protocol based on a generated other session key. At least a portion of the session key is used to generate the other session key.

Abstract: The present invention comprises a process for preparing essentially pure 1,2-dihydro-6-alkyl-2-oxo-5-(pyridinyl)-nicotinonitriles from a crude reaction mixture containing the corresponding amide as an impurity. By "essentially pure" is meant a level of purity acceptable for orally administered pharmaceutical products, usually less than 0.1% of any single impurity. At least a stoichiometric amount of an acylating agent is reacted with the crude reaction mixture, and thereafter recovering essentially pure 1,2-dihydro-6-alkyl-2-oxo 5-(pyridinyl)-nicotinonitrile.

Abstract: A process for preparing 4-aryl-1,2,4-triazol-3-ones and 4-aryl-5-alkoxy-1,2,4-triazol-3-ones. A reaction mixture includes a primary aromatic amine, an alkyl carbazate and a trialkyl orthoformate. The reactants are heated in a reaction vessel in the presence of an acid catalyst and a polar solvent. After the reaction is complete, the solvent is removed, water is added, and the slurry is filtered to isolate 4-aryl-5-alkoxy-1,2,4-triazol-3-one. Alternatively, after the reaction is complete, an alkali metal alkoxide is added to the reaction mixture in the vessel, and the new mixture is again heated until the reaction is complete. The solvent is distilled from the mixture, and the remaining mixture is diluted with water. The slurry is separated from mixture, washed and dried to obtain 4-aryl-1,2,4-triazol-3-one in near 100% yield.